These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Progress in the diagnosis of cutaneous lymphomas. Enzyme cytochemical and immunocytological studies]. Burg G Fortschr Med; 1976 Jun; 94(18):1089-98. PubMed ID: 1085739 [TBL] [Abstract][Full Text] [Related]
8. Cell marker analysis of extranodal lymphoid infiltrates: to what extent does the determination of mono- or polyclonality resolve the diagnostic dilemma of malignant lymphoma v pseudolymphoma in an extranodal site? Knowles DM; Jakobiec FA Semin Diagn Pathol; 1985 Aug; 2(3):163-8. PubMed ID: 3939660 [TBL] [Abstract][Full Text] [Related]
9. An ultrastructural morphometric and immunohistochemical analysis of cutaneous lymphomas and benign lymphocytic infiltrates of skin. Useful criteria for diagnosis. Payne CM; Grogan TM; Lynch PJ Arch Dermatol; 1986 Oct; 122(10):1139-54. PubMed ID: 3490225 [TBL] [Abstract][Full Text] [Related]
10. [Primary cutaneous lymphoma, with the exception of mycosis fungoides]. Joly P; Charlotte F; Leibowitch M; Haioun C; Wechsler J; Dreyfus F; Escande JP; Revuz J; Bagot M Ann Dermatol Venereol; 1992; 119(6-7):457-62. PubMed ID: 1444106 [TBL] [Abstract][Full Text] [Related]
11. Differential diagnosis of malignant and benign cutaneous lymphoid infiltrates: a study of 57 cases in which malignant lymphoma had been diagnosed or suspected in the skin. Evans HL; Winkelmann RK; Banks PM Cancer; 1979 Aug; 44(2):699-717. PubMed ID: 582573 [TBL] [Abstract][Full Text] [Related]
12. Assessment of clonality in cutaneous lymphoid infiltrates by polymerase chain reaction analysis of immunoglobulin heavy chain gene rearrangement. Ritter JH; Wick MR; Adesokan PN; Fitzgibbon JF; Zhu X; Humphrey PA Am J Clin Pathol; 1997 Jul; 108(1):60-8. PubMed ID: 9208979 [TBL] [Abstract][Full Text] [Related]
13. [Colchicine sensitivity index: a means of distinguishing benign and malignant lymphocytic cutaneous infiltrates (author's transl)]. Sterry W; Steigleder GK; Nikolai B Dtsch Med Wochenschr; 1980 Aug; 105(33):1157-9. PubMed ID: 6969652 [TBL] [Abstract][Full Text] [Related]
14. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II. Paulli M; Berti E Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460 [TBL] [Abstract][Full Text] [Related]
15. Mycosis fungoides associated with B-cell malignancies. Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178 [TBL] [Abstract][Full Text] [Related]
16. Histologic criteria for distinguishing between benign and malignant extranodal lymphoid infiltrates. Burke JS Semin Diagn Pathol; 1985 Aug; 2(3):152-62. PubMed ID: 3916552 [TBL] [Abstract][Full Text] [Related]
17. Morphological and functional differentiation and classification of cutaneous lymphomas. Burg G; Braun-Falco O Bull Cancer; 1977; 64(2):225-40. PubMed ID: 303132 [TBL] [Abstract][Full Text] [Related]
18. Classification of non-Hodgkin malignant lymphomas of the skin. Ribuffo A; Chimenti S; Calvieri S; Cantoresi F; Clerico R; Bianchini D; Ribuffo M Int J Tissue React; 1986; 8(2):135-40. PubMed ID: 3486167 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma. Medeiros LJ; Picker LJ; Abel EA; Hu CH; Hoppe RT; Warnke RA; Wood GS J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):929-42. PubMed ID: 2808829 [TBL] [Abstract][Full Text] [Related]
20. Approach to lymphoproliferative infiltrates of the skin. The difficult lesions. Kempf W; Dummer R; Burg G Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S84-93. PubMed ID: 9894473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]